Gene · 1459
Papers2,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenic missense variants of CSNK2B associated with Poirier-Bienvenu neurodevelopmental disorder impact differently on CK2 holoenzyme formation. | Biol Chem | 2025 | 40317201 | PubTator, text mining | PubMed |
| A CK2α' mutant indicating why CK2α and CK2α', the isoforms of the catalytic subunit of human protein kinase CK2, deviate in affinity to CK2β. | Biol Chem | 2025 | 40223482 | PubTator, text mining | PubMed |
| S-palmitoylation of c-MET by CK2α-mediated zDHHC15 phosphorylation drives glioblastoma stem cell tumorigenicity. | Neuro Oncol | 2025 | 40207776 | PubTator, text mining | PubMed |
| Correction: Small molecule induces mitochondrial fusion for neuroprotection via targeting CK2 without affecting its conventional kinase activity. | Signal Transduct Target Ther | 2025 | 40185741 | PubTator, text mining | PubMed |
Subunit specific altered expression and activity of casein kinase 2 in the brain tissues resected from mesial temporal lobe epilepsy with hippocampal sclerosis patients & rodent temporal lobe epilepsy model. | Neuroscience | 2025 | 40064363 | PubTator, text mining | PubMed |
| Exploring the Impact of Microgravity on Gene Expression: Dysregulated Pathways and Candidate Repurposed Drugs. | Int J Mol Sci | 2025 | 39941055 | PubTator, text mining | PubMed |
| Correction: CK2α-mediated phosphorylation of GRP94 facilitates the metastatic cascade in triple-negative breast cancer. | Cell Death Discov | 2025 | 39929814 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal pre-metastatic subsets and therapeutic targets in penile carcinoma. | iScience | 2025 | 39925432 | PubTator, text mining | PubMed |
| Exploring Structural Requirement of Curcumin-Based CK2 Inhibitors as Anticancer Agents: 3D-QSAR, Pharmacophore Modeling, Virtual Screening, and Molecular Docking. | Med Chem | 2025 | 39917934 | PubTator, text mining | PubMed |
| Protein kinase CK2 contributes to glucose homeostasis. | Biol Chem | 2025 | 39910713 | PubTator, text mining | PubMed |
| Correction to "Inhibition of CK2α accelerates skin wound healing by promoting endothelial cell proliferation through the hedgehog signaling pathway". | FASEB J | 2025 | 39887756 | PubTator, text mining | PubMed |
| Binding-Site Switch for Protein Kinase CK2 Inhibitors. | ChemMedChem | 2025 | 39835439 | PubTator, text mining | PubMed |
| CK2α-mediated phosphorylation of DUB3 promotes YAP1 stability and oncogenic functions. | Cell Death Dis | 2025 | 39827153 | PubTator, text mining | PubMed |
| Peptide design to control protein-protein interactions. | Chem Soc Rev | 2025 | 39817557 | PubTator, text mining | PubMed |
| Casein Kinases 2-dependent phosphorylation of the placental ligand VAR2CSA regulates Plasmodium falciparum-infected erythrocytes cytoadhesion. | PLoS Pathog | 2025 | 39804934 | PubTator, text mining | PubMed |
| Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation. | Int J Biol Macromol | 2025 | 39631575 | PubTator, text mining | PubMed |
| Discovery of a novel, selective CK2 inhibitor class with an unusual basic scaffold. | Eur J Med Chem | 2025 | 39566243 | PubTator, text mining | PubMed |
| Nucleolar casein kinase 2 alpha as a prognostic factor in patients with surgically resected early‑stage lung adenocarcinoma. | Oncol Rep | 2025 | 39513582 | PubTator, text mining | PubMed |
| Inhibition of the long non-coding RNA MALAT1 downregulates MAP2K1, suppressing the progression of hypopharyngeal squamous cell carcinoma. | Biomol Biomed | 2025 | 39319867 | PubTator, text mining | PubMed |
| FGF21 Ameliorates Fibroblasts Activation and Systemic Sclerosis by Inhibiting CK2α/GLI2 Signaling Axis. | J Invest Dermatol | 2025 | 39182559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1459/papers?page=4